Overview of strategies for overcoming the challenge of antimicrobial resistance

References

• Verheij TJ. The antibiotic revolution should be more focused. Br. J. Gen. Pract.59(567), 716–717 (2009).
   Google Scholar
• Macfarlane JT, Worboys M. The changing management of acute bronchitis in Britain, 1940–1970: the impact of antibiotics. Med. Hist.52(1), 47–72 (2008).
   Google Scholar
• Sykes R. The evolution of antimicrobial resistance: a Darwinian perspective. J. Antimicrob. Chemother. (2010) (In press).
   Google Scholar
• Monnet D, Kristinsson K. Turning the tide of antimicrobial resistance: Europe shows the way. Euro Surveill.13(46), 1–2 (2008).
   Google Scholar
• Morel CM, Mossialos E. Stoking the antibiotic pipeline. Br. Med. J.340, c2115 (2010).
   PubMedGoogle Scholar
• So AD, Gupta N, Cars O. Tackling antibiotic resistance. Br. Med. J.340, c2071 (2010).
   Google Scholar
• Dellit TH, Owens RC, McGowan JE Jr et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin. Infect. Dis.44(2), 159–177 (2007).
   PubMed Web of Science ®Google Scholar
• Dryden M, Hand K, Davey P. Antibiotics for community-acquired pneumonia. J. Antimicrob. Chemother.64(6), 1123–1125 (2009).
   Google Scholar
• Isenberg HD. Pathogenicity and virulence: another view. Clin. Microbiol. Rev.1, 40–53 (1988).
   PubMedGoogle Scholar
• Paterson DL. ‘Collateral damage’ from cephalosporin or quinolone antibiotic therapy. Clin. Infect. Dis.38(Suppl. 4), S341–S345 (2004).
   PubMed Web of Science ®Google Scholar
• Guillemot D, Varon E, Bernede C et al. Reduction of antibiotic use in the community reduces the rate of colonization with penicillin G-nonsusceptible Streptococcus pneumoniae.Clin. Infect. Dis.41(7), 930–938 (2005).
   PubMed Web of Science ®Google Scholar
• Guillemot D, Carbon C, Balkau B et al. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae.JAMA279, 365–370 (1998).
   PubMed Web of Science ®Google Scholar
• Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin. Microbiol. Infect.12(Suppl. 6), 2–18 (2006).
   PubMed Web of Science ®Google Scholar
• Srinivasan A, Song X, Richards A, Sinkowitz-Cochran R, Cardo D, Rand C. A survey of knowledge, attitudes, and beliefs of house staff physicians from various specialties concerning antimicrobial use and resistance. Arch. Intern. Med.164(13), 1451–1456 (2004).
   PubMedGoogle Scholar
• Easton PM, Sarma A, Williams FL, Marwick CA, Phillips G, Nathwani D. Infection control and management of MRSA: assessing the knowledge of staff in an acute hospital setting. J. Hosp. Infect.66(1), 29–33 (2007).
   Google Scholar
• Simpson SA, Wood F, Butler CC. General practitioners’ perceptions of antimicrobial resistance: a qualitative study. J. Antimicrob. Chemother.59(2), 292–296 (2007).
   PubMed Web of Science ®Google Scholar
• Furuya EY, Lowy FD. Antimicrobial-resistant bacteria in the community setting. Nat. Rev. Microbiol.4(1), 36–45 (2006).
   PubMed Web of Science ®Google Scholar
• Arason VA, Sigurdsson JA, Erlendsdottir H, Gudmundsson S, Kristinsson KG. The role of antimicrobial use in the epidemiology of resistant pneumococci: a 10-year follow up. Microb. Drug Resist.12(3), 169–176 (2006).
   Google Scholar
• Oliveira DC, Tomasz A, de Lencastre H. Secrets of success of a human pathogen: molecular evolution of pandemic clones of methicillin-resistant Staphylococcus aureus.Lancet Infect. Dis.2(3), 180–189 (2002).
   PubMed Web of Science ®Google Scholar
• Monnet DL, MacKenzie FM, Lopez-Lozano JM et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996–2000. Emerg. Infect. Dis.10(8), 1432–1441 (2004).
   PubMed Web of Science ®Google Scholar
• Gomes AR, Westh H, de Lencastre H. Origins and evolution of methicillin-resistant Staphylococcus aureus clonal lineages. Antimicrob. Agents Chemother.50(10), 3237–3244 (2006).
   Google Scholar
• Patrick DM, Hutchinson J. Antibiotic use and population ecology: how you can reduce your ‘resistance footprint’. CMAJ180(4), 416–421 (2009).
   PubMed Web of Science ®Google Scholar
• Mulvey MR, Simor AE. Antimicrobial resistance in hospitals: how concerned should we be? CMAJ180(4), 408–415 (2009).
   PubMed Web of Science ®Google Scholar
• Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. Br. Med. J.340, c2096 (2010).
   PubMed Web of Science ®Google Scholar
• Johnsen PJ, Townsend JP, Bohn T, Simonsen GS, Sundsfjord A, Nielsen KM. Factors affecting the reversal of antimicrobial-drug resistance. Lancet Infect. Dis.9(6), 357–364 (2009).
   PubMed Web of Science ®Google Scholar
• Austin DJ, Kristinsson KG, Anderson RM. The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance. Proc. Natl Acad. Sci. USA96, 1152–1156 (1999).
   PubMed Web of Science ®Google Scholar
• Levin BR. Minimizing potential resistance: a population dynamics view. Clin. Infect. Dis.33(Suppl. 3), S161–S169 (2001).
   PubMed Web of Science ®Google Scholar
• Lipsitch M. The rise and fall of antimicrobial resistance. Trends Microbiol.9(9), 438–444 (2001).
   PubMed Web of Science ®Google Scholar
• Gustafsson I, Cars O, Andersson DI. Fitness of antibiotic resistant Staphylococcus epidermidis assessed by competition on the skin of human volunteers. J. Antimicrob. Chemother.52(2), 258–263 (2003).
   Google Scholar
• Komp Lindgren P, Marcusson LL, Sandvang D, Frimodt-Moller N, Hughes D. Biological cost of single and multiple norfloxacin resistance mutations in Escherichia coli implicated in urinary tract infections. Antimicrob. Agents Chemother.49(6), 2343–2351 (2005).
   Google Scholar
• Rozen DE, McGee L, Levin BR, Klugman KP. Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae.Antimicrob. Agents Chemother.51(2), 412–416 (2007).
   PubMedGoogle Scholar
• Lipsitch M, Bergstrom CT, Levin BR. The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions. Proc. Natl Acad. Sci. USA97(4), 1938–1943 (2000).
   PubMed Web of Science ®Google Scholar
• Anonymous. Severe Clostridium difficile-associated disease in populations previously at low risk – four states, 2005. MMWR Morb. Mortal. Wkly Rep.54(47), 1201–1205 (2005).
   PubMedGoogle Scholar
• Loo VG, Poirier L, Miller MA et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med.353(23), 2442–2449 (2005).
   PubMed Web of Science ®Google Scholar
• Song X, Bartlett JG, Speck K, Naegeli A, Carroll K, Perl TM. Rising economic impact of Clostridium difficile- associated disease in adult hospitalized patient population. Infect. Control Hosp. Epidemiol.29(9), 823–828 (2008).
   PubMed Web of Science ®Google Scholar
• Pepin J, Saheb N, Coulombe MA et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin. Infect. Dis.41(9), 1254–1260 (2005).
   PubMed Web of Science ®Google Scholar
• Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ173(9), 1037–1042 (2005).
   PubMed Web of Science ®Google Scholar
• Warny M, Pepin J, Fang A et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet366(9491), 1079–1084 (2005).
   PubMed Web of Science ®Google Scholar
• Carignan A, Allard C, Pepin J, Cossette B, Nault V, Valiquette L. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin. Infect. Dis.46(12), 1838–1843 (2008).
   Google Scholar
• Barbut F, Mastrantonio P, Delmee M, Brazier J, Kuijper E, Poxton I. Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates. Clin. Microbiol. Infect.13(11), 1048–1057 (2007).
   PubMed Web of Science ®Google Scholar
• Donnan PT, Wei L, Steinke DT et al. Presence of bacteriuria caused by trimethoprim resistant bacteria in patients prescribed antibiotics: multilevel model with practice and individual patient data. Br. Med. J.328(7451), 1297 (2004).
   PubMedGoogle Scholar
• Leibovici L, Berger R, Gruenewald T et al. Departmental consumption of antibiotic drugs and subsequent resistance: a quantitative link. J. Antimicrob. Chemother.48, 535–540 (2001).
   Google Scholar
• Chung A, Perera R, Brueggemann AB et al. Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study. Br. Med. J.335(7617), 429 (2007).
   PubMed Web of Science ®Google Scholar
• Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goossens H. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet369(9560), 482–490 (2007).
   PubMed Web of Science ®Google Scholar
• Beaugerie L, Flahault A, Barbut F et al. Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment. Pharmacol. Ther.17(7), 905–912 (2003).
   PubMed Web of Science ®Google Scholar
• Hirschhorn LR, Trnka Y, Onderdonk A, Lee ML, Platt R. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J. Infect. Dis.169(1), 127–133 (1994).
   PubMed Web of Science ®Google Scholar
• Pulcini C, Williams F, Molinari N, Davey P, Nathwani D. Junior doctors’ knowledge and perceptions of antibiotic resistance and prescribing: a survey in France and Scotland. Clin. Microbiol. Infect. DOI: 10.1111/j.1469-0691.2010.03179.x (2010).
   Google Scholar
• Askarian M, Mirzaei K, Mundy LM, McLaws ML. Assessment of knowledge, attitudes, and practices regarding isolation precautions among Iranian healthcare workers. Infect. Control Hosp. Epidemiol.26(1), 105–108 (2005).
   Google Scholar
• De Souza V, MacFarlane A, Murphy AW, Hanahoe B, Barber A, Cormican M. A qualitative study of factors influencing antimicrobial prescribing by non-consultant hospital doctors. J. Antimicrob. Chemother.58(4), 840–843 (2006).
   PubMedGoogle Scholar
• van Gemert-Pijnen J, Hendrix MG, van der Palen J, Schellens PJ. Performance of methicillin-resistant Staphylococcus aureus protocols in Dutch hospitals. Am. J. Infect. Control33(7), 377–384 (2005).
   Google Scholar
• Pessoa-Silva CL, Posfay-Barbe K, Pfister R, Touveneau S, Perneger TV, Pittet D. Attitudes and perceptions toward hand hygiene among healthcare workers caring for critically ill neonates. Infect. Control Hosp. Epidemiol.26(3), 305–311 (2005).
   PubMed Web of Science ®Google Scholar
• Tsagkaraki AP, Sampaziotis F, Cooke FJ, Gkrania-Klotsas E. Assessing staff knowledge about Clostridium difficile diarrhoea. J. Hosp. Infect.72(1), 81–83 (2009).
   Google Scholar
• Hart AM, Pepper GA, Gonzales R. Balancing acts: deciding for or against antibiotics in acute respiratory infections. J. Fam. Pract.55(4), 320–325 (2006).
   Google Scholar
• Davey PG, Pagliari C, Hayes A. The patient’s role in the spread and control of bacterial resistance to antibiotics. Clin. Microbiol. Infect.8(2), 43–68 (2002).
   PubMed Web of Science ®Google Scholar
• McNulty CA, Boyle P, Nichols T, Clappison P, Davey P. Don’t wear me out – the public’s knowledge of and attitudes to antibiotic use. J. Antimicrob. Chemother.59(4), 727–738 (2007).
   PubMed Web of Science ®Google Scholar
• Easton PM, Marwick CA, Williams FL et al. A survey on public knowledge and perceptions of methicillin-resistant Staphylococcus aureus.J. Antimicrob. Chemother.63(1), 209–214 (2009).
   Google Scholar
• Collins JP, Roberts DM, Evans CF, De’Ath HD, Galland RB. Public perception of Clostridium difficile.J. Hosp. Infect.72(1), 80–81 (2009).
   Google Scholar
• Burnett E, Lee K, Rushmer R, Ellis M, Noble M, Davey P. Healthcare-associated infection and the patient experience: a qualitative study using patient interviews. J. Hosp. Infect.74(1), 42–47. (2009).
   Google Scholar
• Nicolle L, Conly JM, MacDonald N. Embracing ecology to limit antimicrobial resistance. CMAJ180(4), 371–372 (2009).
   Google Scholar
• Aldeyab MA, Harbarth S, Vernaz N et al. Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients. Antimicrob. Agents Chemother.53(5), 2082–2088 (2009).
   Google Scholar
• Vernaz N, Hill K, Leggeat S et al. Temporal effects of antibiotic use and Clostridium difficile infections. J. Antimicrob. Chemother.63(6), 1272–1275 (2009).
   Google Scholar
• Coenen S, Muller A, Adriaenssens N, Vankerckhoven V, Hendrickx E, Goossens H. European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe. J. Antimicrob. Chemother.64(1), 200–205 (2009).
   Google Scholar
• Goossens H, Ferech M, Vander SR, Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet365(9459), 579–587 (2005).
   PubMed Web of Science ®Google Scholar
• Davey P, Ferech M, Ansari F, Muller A, Goossens H; on behalf of the ESAC Project Group. Outpatient antibiotic use in the four administrations of the UK: cross-sectional and longitudinal analysis. J. Antimicrob. Chemother.62(6), 1441–1447 (2008).
   Google Scholar
• Ansari F, Erntell M, Goossens H, Davey P. The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin. Infect. Dis.49(10), 1496–1504 (2009).
   PubMed Web of Science ®Google Scholar
• Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H; on behalf of the European Surveillance of Antibiotic Consumption Project G. Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997–2002). J. Antimicrob. Chemother.58(1), 159–167 (2006).
   PubMed Web of Science ®Google Scholar
• World Health Organization Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment, WHO Collaborating Centre for Drug Statistics Methodology, Oslo, Norway (2006).
   Google Scholar
• Henderson KL, Müller-Pebody B, Johnson AP, Goossens H, Sharland M; on behalf of the ARPEC Group. First set-up meeting for antibiotic resistance and prescribing in European children (ARPEC). Euro Surveill.14(45), pii: 19404. (2009).
   Google Scholar
• Vermeulen LC, Vulto AG, Zellmer WA. Editorial: the promise of Basel. Am. J. Health Syst. Pharm.66(5 Suppl. 3), S7 (2009).
   Google Scholar
• Gandhi T, Flanders SA, Markovitz E, Saint S, Kaul DR. Importance of urinary tract infection to antibiotic use among hospitalized patients. Infect. Control Hosp. Epidemiol.30(2), 193–195 (2009).
   Google Scholar
• Hermanides HS, Hulscher ME, Schouten JA, Prins JM, Geerlings SE. Development of quality indicators for the antibiotic treatment of complicated urinary tract infections: a first step to measure and improve care. Clin. Infect. Dis.46(5), 703–711 (2008).
   PubMed Web of Science ®Google Scholar
• Christ-Crain M, Jaccard-Stolz D, Bingisser R et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet363(9409), 600–607 (2004).
   PubMed Web of Science ®Google Scholar
• Goossens H, Ferech M, Coenen S, Stephens P. Comparison of outpatient systemic antibacterial use in 2004 in the United States and 27 European countries. Clin. Infect. Dis.44(8), 1091–1095 (2007).
   PubMed Web of Science ®Google Scholar
• Wang KY, Seed P, Schofield P, Ibrahim S, Ashworth M. Which practices are high antibiotic prescribers? A cross-sectional analysis. Br. J. Gen. Pract.59(567), e315–e320 (2009).
   PubMed Web of Science ®Google Scholar
• Kuyvenhoven M, van Essen G, Schellevis F, Verheij T. Management of upper respiratory tract infections in Dutch general practice; antibiotic prescribing rates and incidences in 1987 and 2001. Fam. Pract.23(2), 175–179 (2006).
   PubMedGoogle Scholar
• Butler CC, Hood K, Verheij T et al. Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. Br. Med. J.338, b2242 (2009).
   PubMed Web of Science ®Google Scholar
• McNulty C, Boyle P, Nichols T, Clappison P, Davey P. Left-over antimicrobials in the home, United Kindom. Emerg. Infect. Dis.12(10), 1523–1526 (2006).
   Google Scholar
• Grigoryan L, Haaijer-Rysjamp FM, Burgerhof JG et al. Self-medication with antimicrobial drugs in Europe. Emerg. Infect. Dis.12(3), 452–459 (2006).
   PubMed Web of Science ®Google Scholar
• Grigoryan L, Burgerhof JG, Degener JE et al. Determinants of self-medication with antibiotics in Europe: the impact of beliefs, country wealth and the healthcare system. J. Antimicrob. Chemother.61(5), 1172–1179 (2008).
   PubMed Web of Science ®Google Scholar
• Davey P, Brown E, Fenelon L et al. Systematic review of antimicrobial drug prescribing in hospitals. Emerg. Infect. Dis.12(2), 211–216 (2006).
   PubMed Web of Science ®Google Scholar
• Coenen S, Ferech M, Haaijer-Ruskamp FM et al. European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual. Saf. Health Care16(6), 440–445 (2007).
   PubMed Web of Science ®Google Scholar
• Granizo JJ, Aguilar L, Casal J, Dal Re R, Baquero F. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986–1997). J. Antimicrob. Chemother.46(6), 959–964 (2000).
   PubMed Web of Science ®Google Scholar
• Granizo JJ, Aguilar L, Casal J, Garcia-Rey C, Dal Re R, Baquero F. Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and β-lactam consumption in Spain (1979–1997). J. Antimicrob. Chemother.46(5), 767–773 (2000).
   PubMed Web of Science ®Google Scholar
• Rice LB. The Maxwell Finland Lecture: for the duration-rational antibiotic administration in an era of antimicrobial resistance and Clostridium difficile.Clin. Infect. Dis.46(4), 491–496 (2008).
   PubMed Web of Science ®Google Scholar
• el Moussaoui R, de Borgie CAJM, van den Broek P et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. Br. Med. J.332(7554), 1355 (2006).
   PubMed Web of Science ®Google Scholar
• Chastre J, Wolff M, Fagon JY et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA290(19), 2588–2598 (2003).
   PubMed Web of Science ®Google Scholar
• Cochrane Effective Practice and Organisation of Care (EPOC) Group. EPOC resources for review authors. EPOC Resources for Review Authors1–26 (2009).
   Google Scholar
• Stone SP, Cooper BS, Kibbler CC et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect. Dis.7(4), 282–288 (2007).
   Google Scholar
• Shardell M, Harris AD, El-Kamary SS, Furuno JP, Miller RR, Perencevich EN. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin. Infect. Dis.45(7), 901–907 (2007).
   PubMed Web of Science ®Google Scholar
• Harris AD, Lautenbach E, Perencevich E. A systematic review of quasi-experimental study designs in the fields of infection control and antibiotic resistance. Clin. Infect. Dis.41(1), 77–82 (2005).
   PubMed Web of Science ®Google Scholar
• Arnold SR, Straus SE. Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst. Rev.(4), CD003539 (2005).
   Google Scholar
• Davey P, Brown E, Fenelon L et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst. Rev.(4), CD003543 (2005).
   Google Scholar
• Davey PG, Nathwani D, Rubinstein E. Antibiotic policies. In: Antibiotic and Chemotherapy (9th Edition). Finch RG, Greenwood D, Norrby R (Eds). Elsevier, London UK (2010) (In press).
   Google Scholar
• Kliger I. Auto-historiography: genre, trope, and modes of emplotment in Aleksandr and Natal’ja Gercen’s narratives of the family drama. Russian Literature61(1–2), 103–138 (2007).
   Google Scholar
• Goossens H, Coenen S, Costers M et al. Achievements of the Belgian Antibiotic Policy Coordination Committee (BAPCOC). Euro Surveill.13(46), pii: 19036 (2008).
   Google Scholar
• Rautakorpi UM, Huikko S, Honkanen P et al. The Antimicrobial Treatment Strategies (MIKSTRA) program: a 5-year follow-up of infection-specific antibiotic use in primary health care and the effect of implementation of treatment guidelines. Clin. Infect. Dis.42(9), 1221–1230 (2006).
   PubMed Web of Science ®Google Scholar
• Sabuncu E, David J, Bernede-Bauduin C et al. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002–2007. PLoS Med.6(6), e1000084 (2009).
   PubMed Web of Science ®Google Scholar
• Molstad S, Erntell M, Hanberger H et al. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect. Dis.8(2), 125–132 (2008).
   PubMed Web of Science ®Google Scholar
• Molstad S, Cars O, Struwe J. Strama – a Swedish working model for containment of antibiotic resistance. Euro Surveill.13(46), pii: 19041 (2008).
   Google Scholar
• Meropol SB, Chen Z, Metlay JP. Reduced antibiotic prescribing for acute respiratory infections in adults and children. Br. J. Gen. Pract.59(567), e321–e328 (2009).
   Google Scholar
• Lambert MF, Masters GA, Brent SL. Can mass media campaigns change antimicrobial prescribing? A regional evaluation study. J. Antimicrob. Chemother.59(3), 537–543 (2007).
   PubMed Web of Science ®Google Scholar
• Seppala H, Klaukka T, Vuopio-Varkila J et al. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A Streptococci in Finland. N. Engl. J. Med.337, 441–446 (1997).
   PubMed Web of Science ®Google Scholar
• Anonymous. Recent trends in antimicrobial resistance among Streptococcus pneumoniae and Staphylococcus aureus isolates: the French experience. Euro Surveill.13(46), pii: 19035 (2008).
   Google Scholar
• Gottesman BS, Carmeli Y, Shitrit P, Chowers M. Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting. Clin. Infect. Dis.49(6), 869–875 (2009).
   Google Scholar
• Davey P, Urquhart L. Will a reduction in community prescribing of quinolones decrease the prevalence of quinolone resistance? Clin. Infect. Dis.49(6), 876–877 (2009).
   Google Scholar
• Kyaw MH, Lynfield R, Schaffner W et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.N. Engl. J. Med.354(14), 1455–1463 (2006).
   PubMed Web of Science ®Google Scholar
• Lan CK, Hsueh PR, Wong WW et al. Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum β-lactamase-producing organisms. J. Microbiol. Immunol. Infect.36(3), 182–186 (2003).
   PubMedGoogle Scholar
• Lee SO, Lee ES, Park SY, Kim SY, Seo YH, Cho YK. Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum β-lactamase-producing Klebsiella pneumoniae.Infect. Control Hosp. Epidemiol.25(10), 832–837 (2004).
   PubMed Web of Science ®Google Scholar
• Madaras-Kelly KJ, Remington RE, Lewis PG, Stevens DL. Evaluation of an intervention designed to decrease the rate of nosocomial methicillin-resistant Staphylococcus aureus infection by encouraging decreased fluoroquinolone use. Infect. Control Hosp. Epidemiol.27(2), 155–169 (2006).
   PubMed Web of Science ®Google Scholar
• Charbonneau P, Parienti JJ, Thibon P et al. Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study. Clin. Infect. Dis.42(6), 778–784 (2006).
   PubMed Web of Science ®Google Scholar
• Fowler S, Webber A, Cooper BS et al. Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. J. Antimicrob. Chemother.59(5), 990–998 (2007).
   PubMed Web of Science ®Google Scholar
• Weiss K, Boisvert A, Chagnon M et al. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007. Infect. Control Hosp. Epidemiol.30(2), 156–162 (2009).
   PubMed Web of Science ®Google Scholar
• Paul M, Andreassen S, Tacconelli E et al. Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial. J. Antimicrob. Chemother.58(6), 1238–1245 (2006).
   PubMedGoogle Scholar
• Cooper BS, Stone SP, Kibbler CC et al. Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): systematic review of the literature. Br. Med. J.329(7465), 533–541 (2004).
   PubMed Web of Science ®Google Scholar
• Robicsek A, Beaumont JL, Paule SM et al. Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann. Intern. Med.148(6), 409–418 (2008).
   PubMed Web of Science ®Google Scholar
• Marwick C, Davey P. Care bundles: the holy grail of infectious risk management in hospital? Curr. Opin. Infect. Dis.22(4), 364–369 (2009).
   PubMedGoogle Scholar
• Petersen I, Johnson AM, Islam A, Duckworth G, Livermore DM, Hayward AC. Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research Database. Br. Med. J.335(7627), 982–988 (2007).
   PubMed Web of Science ®Google Scholar
• Cals JW, Butler CC, Hopstaken RM, Hood K, Dinant GJ. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. Br. Med. J.338, b1374 (2009).
   PubMed Web of Science ®Google Scholar
• Vinogradova Y, Hippisley-Cox J, Coupland C. Identification of new risk factors for pneumonia: population-based case–control study. Br. J. Gen. Pract.59(567), e329–e338 (2009).
   PubMed Web of Science ®Google Scholar
• Moore M, Little P, Rumsby K et al. Effect of antibiotic prescribing strategies and an information leaflet on longer-term reconsultation for acute lower respiratory tract infection. Br. J. Gen. Pract.59(567), 728–734 (2009).
   PubMed Web of Science ®Google Scholar
• Loeb M, Brazil K, Lohfeld L et al. Effect of a multifaceted intervention on number of antimicrobial prescriptions for suspected urinary tract infections in residents of nursing homes: cluster randomised controlled trial. Br. Med. J.331(7518), 669 (2005).
   PubMedGoogle Scholar
• Christ-Crain M, Stolz D, Bingisser R et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am. J. Respir. Crit. Care Med.174(1), 84–93 (2006).
   PubMed Web of Science ®Google Scholar
• Meyer E, Buttler J, Schneider C et al. Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced. J. Antimicrob. Chemother.59(6), 1148–1154 (2007).
   PubMedGoogle Scholar
• Micek ST, Ward S, Fraser VJ, Kollef MH. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest125(5), 1791–1799 (2004).
   PubMed Web of Science ®Google Scholar
• van Kasteren ME, Mannien J, Kullberg BJ et al. Quality improvement of surgical prophylaxis in Dutch hospitals: evaluation of a multi-site intervention by time series analysis. J. Antimicrob. Chemother.56(6), 1094–1102 (2005).
   PubMed Web of Science ®Google Scholar
• Schuetz P, Christ-Crain M, Thomann R et al. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA302(10), 1059–1066 (2009).
   PubMed Web of Science ®Google Scholar
• Briel M, Schuetz P, Mueller B et al. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care. Arch. Intern. Med.168(18), 2000–2007 (2008).
   PubMed Web of Science ®Google Scholar
• Van Kasteren ME, Mannien J, Ott A, Kullberg BJ, De Boer AS, Gyssens IC. Antibiotic prophylaxis and the risk of surgical site infections following total hip arthroplasty: timely administration is the most important factor. Clin. Infect. Dis.44(7), 921–927 (2007).
   PubMed Web of Science ®Google Scholar
• Earnshaw S, Monnet DL, Duncan B, O’Toole J, Ekdahl K, Goossens H. European Antibiotic Awareness Day, 2008 – the first Europe-wide public information campaign on prudent antibiotic use: methods and survey of activities in participating countries. Euro Surveill.14(30), 19280 (2009).
   PubMedGoogle Scholar
• Allerberger F, Gareis R, Jindrak V, Struelens MJ. Antibiotic stewardship implementation in the EU: the way forward. Expert Rev. Anti Infect. Ther.7(10), 1175–1183 (2009).
   PubMed Web of Science ®Google Scholar
• Resar R, Pronovost P, Haraden C, Simmonds T, Rainey T, Nolan T. Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm. J. Qual. Patient Saf.31(5), 243–248 (2005).
   PubMedGoogle Scholar